FDA releases silicone breast implants from tracking rules
This article was originally published in Clinica
Executive Summary
The US FDA has exempted a number of manufacturers from its mandatory tracking requirements after concluding that their products are not risky enough to warrant the added regulatory burden. The exemption includes companies that make silicone gel implants and saline breast implants.